Skip to main content
Screener/Healthcare/Biotechnology

CHRS — Coherus Oncology, Inc.

NASDAQ
$1.26-0.07 (-4.89%)
Micro CapPenny StockUnder $5Healthcare
$1.09
$2.62
$1.26
$1.35
EPS (TTM)$-1.28
P/E Ratio1.27
Dividend Yield—
Market Cap$211.7M
Volume571K
Prev Close$1.33
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$12.3M-$38.3M$-0.280.0%-311.3%
Q4 '25$12.7M-$37.6M$-0.3168.3%-295.3%
Q3 '25$11.6M-$35.5M$-0.3067.8%-307.1%
Q2 '25$10.3M$297.8M$-0.3966.9%2903.9%
Q1 '25$7.6M-$56.6M$-0.4965.1%-744.4%
Q4 '24$54.1M-$50.7M$-0.4437.5%-93.6%
Q3 '24$70.8M-$10.8M$-0.0970.7%-15.2%
Q2 '24$65.0M-$12.9M$-0.1154.5%-19.9%
Get Your Daily Market Recap